Developing treatments for serious metabolic diseases like MASH.
| Title |
|---|
| Associate Director, Drug Product Development Full Time · $153K-$218K · 7+ YOE California, United States · Remote |
| Principal Scientist, CMC Analytical Development Full Time · $153K-$218K · 5+ YOE South San Francisco or United States · Remote |
| Manager of Quality Assurance Product Complaints Full Time · $120K-$184K · 7+ YOE United States · Remote |
| Associate Director of GCP Quality Assurance Full Time · $153K-$267K · 9+ YOE South San Francisco or United States · Remote |
| Director /Sr. Director - Clinical Development Full Time · $182K-$318K · 3+ YOE United States · Remote |
| Activities | Drug discoveryClinical trial developmentBiopharmaceutical researchMetabolic disease therapeuticsHepatology treatment development |
| Headquarters | US |
| Industries | BiotechnologyPharmaceuticals |
| Name | Akero Therapeutics |
| Employees | 150 |
| Type | Private |
| Parent Company | Novo Nordisk |
| Tagline | Developing treatments for serious metabolic diseases like MASH. |
| Founded | 2,017 |
| Website | akerotx.com |
| Latest Funding Round | Post-IPO Equity |
| Latest Funding Year | 2,022 |
| Latest Funding Amount | 200,000,000 |
| Latest Investors | Janus Henderson Investors |